Gapping S&P500 stocks in Thursday's session
By Mill Chart
Last update: Apr 25, 2024
Seeking insights into today's market movers? Discover the S&P500 gap up and gap down stocks in today's session on Thursday. Stay informed about the latest market trends.
Gap down stocks
| Ticker | Change | Comment |
|---|---|---|
| TXT | -11.97% | During Thursday's session, TEXTRON INC's (NYSE:TXT) stock price decreased by 11.97% to $82.76 with a significant 13.91% gap. yesterday the company released their earnings. Earlier today the company had a press release: Textron Reports First Quarter 2024 Results. |
| META | -11.11% | META PLATFORMS INC-CLASS A's (NASDAQ:META) shares recorded a 11.11% decline to $438.69, with a notable 18.73% gap during today's session. In the last 3 months the stock gained 25.21%. |
| IBM | -8.82% | INTL BUSINESS MACHINES CORP's (NYSE:IBM) shares fell 8.82% to $167.86 during Thursday's session with a gap of 10.11%. The stock is trading 29.17% higher than 6 months ago. |
| LUV | -7.53% | Today, SOUTHWEST AIRLINES CO's (NYSE:LUV) stock experienced a 7.53% fall to $27.09 with a 11.56% gap. SOUTHWEST AIRLINES CO released earnings Yesterday. In the last 6 months the share price increased with 31.15%. |
| BMY | -7.39% | BRISTOL-MYERS SQUIBB CO's (NYSE:BMY) stock price is declining with 7.39% to a price of $45.25 with a gap of 8.02%. yesterday the company released their earnings. Earlier today the company had a press release: Bristol Myers Squibb Reports First Quarter Financial Results for 2024. |
| DECK | -7.12% | DECKERS OUTDOOR CORP's (NYSE:DECK) shares experienced a 7.12% decline to $791.06 during Thursday's session, accompanied by a 8.05% gap. In the last 6 months the share price increased with 47.77%. |
| CAT | -7.03% | CATERPILLAR INC's (NYSE:CAT) shares recorded a 7.03% decline to $337.95, with a notable 10.28% gap during today's session. The company's earnings where released Yesterday. The stock is trading 21.4% higher than 3 months ago. |
| RJF | -6.7% | Unfortunate news for RAYMOND JAMES FINANCIAL INC's (NYSE:RJF) stock! It registered a 6.7% decline to $119.0 in today's session, accompanied by a 7.76% gap. A press release (Raymond James Financial Reports Fiscal Second Quarter of 2024 Results) was released yesterday. |
| ORLY | -6.69% | O'REILLY AUTOMOTIVE INC's (NASDAQ:ORLY) shares suffered a 6.69% decline to $1.02K during Thursday's session, accompanied by a 8.12% gap. |
| CMCSA | -6.57% | COMCAST CORP-CLASS A's (NASDAQ:CMCSA) stock price decreased by 6.57% to $37.57 with a gap of 7.56%. yesterday the company released their earnings. Earlier today the company had a press release: Comcast Reports 1st Quarter 2024 Results. |
To see the full list of gap down stocks you can use our gap down stocks screener.
BRISTOL-MYERS SQUIBB CO
NYSE:BMY (5/6/2024, 1:44:09 PM)
43.94
-0.05 (-0.11%)
BMY News
37 minutes ago - InvestorPlaceMaximize Your Dividends: 7 Stocks Trading Under $50 with 5%+ YieldsInvesting in high-yield dividend stocks under $50 is a low-risk strategy that can result in massive returns in time.
8 hours ago - Bristol Myers SquibbEuropean Medicines Agency Validates Bristol Myers Squibb’s Application for Opdivo (nivolumab) Plus Yervoy (ipilimumab) for the First-Line Treatment of Adult Patients with Microsatellite...
8 hours ago - Bristol Myers SquibbU.S. Food and Drug Administration Accepts Bristol Myers Squibb’s Application for Subcutaneous Nivolumab (nivolumab and hyaluronidase)
9 hours ago - InvestorPlaceUncover the Potential: 3 Discounted Stocks Ready for a ComebackInvestors should considered these discounted stocks to buy for generous returns due to current undervaluation and strong fundamentals.
3 days ago - Market News VideoBMY June 14th Options Begin Trading
3 days ago - The Motley FoolCould Investing $100,000 in Bristol Myers Squibb Stock Make You a Millionaire?Keep your goals in check when considering an extreme contrarian trade with Bristol Myers Squibb stock.
Keep your goals in check when considering an extreme contrarian trade with Bristol Myers Squibb stock.
3 days ago - The Motley FoolIf You'd Invested $1,000 in Bristol Myers Squibb 5 Years Ago, Here's How Much You'd Have TodayThe answer isn't great, but there's still reason to like Bristol Myers Squibb.
5 days ago - Editas Medicine, Inc.Editas Medicine and Bristol Myers Squibb Extend Alpha-Beta T Cell CollaborationTwo-year extension for research and development of alpha-beta T cell medicines for the treatment of cancer and autoimmune diseases
5 days ago - The Motley Fool3 Top ETFs to Buy for Passive Income in MayThese ETFs provide investors with above-average income streams.
6 days ago - Market News VideoBMY July 19th Options Begin Trading
7 days ago - Repertoire Immune MedicinesRepertoire® Immune Medicines and Bristol Myers Squibb Announce Multi-Year Strategic Collaboration to Develop Tolerizing Vaccines for Autoimmune Diseases/PRNewswire/ -- Repertoire® Immune Medicines, a biotechnology company pioneering the discovery and development of programmable T cell targeted immune...
